BM

BOBBY MCMILLIN

ARNOLD & PORTER KAYE SCHOLER LLP · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
11
last 3 years
Filings
32
7 agencies contacted
Activity
filings by quarter
Works on

Background

Government experience
General Counsel
Senate Committee on Health, Education, Labor, & Pensions
HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-2013); Press Intern, Sen. Chambliss (2007
Disclosed on LD-2 filings
Career
Washington, DC
2024 - present

Specific issues

Issues related to implementation of the Inflation Reduction Act (IRA, P.L. 117-169).
Medicare/Medicaid · 2024 Q3
Issues related to R&D tax credits, including the Tax Relief for American Families and Workers Act of 2024 (H.R. 7024).
Taxation/Internal Revenue Code · 2024 Q3
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program, including the Bipartisan 340B Senate Working Group's discussion draft of the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act). Issues related to biopharmaceutical intellectual property and patent matters.
Health Issues · 2024 Q3
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (Pub. L. No. 117-169), including implementation. Issues related to the Small Biotech Innovation Act (S. 5029).
Medicare/Medicaid · 2024 Q3
Issues related to biopharmaceutical intellectual property and patent matters.
Copyright/Patent/Trademark · 2024 Q3
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Medicare/Medicaid · 2024 Q3

Clients

2024 · 4 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 2 filings
$██,███ / qtrUnlock
2024 · 2 filings
$██,███ / qtrUnlock

Filing history

2024 Q3
PHARMAESSENTIA USA CORPORATION
Q3lda.gov →
2024 Q3
EXELIXIS, INC.
Q3lda.gov →
2024 Q3
FRATERNAL GOVERNMENT RELATIONS COALITION
Q3lda.gov →
2024 Q3
GENETIX BIOTHERAPEUTICS, INC.
Q3lda.gov →
2024 Q3
NOVO NORDISK, INC.
Q3lda.gov →
2024 Q3
GRIFOLS SHARED SERVICES NORTH AMERICA, INC.
Q3lda.gov →
2024 Q3
NOVO NORDISK A/S
Q3lda.gov →
2024 Q3
WILLIAM & MARY FOUNDATION
Q3lda.gov →
2024 Q3
CALBRIGHT COLLEGE
Q3lda.gov →
2024 Q3
PHARMAESSENTIA USA CORPORATION
RAlda.gov →
2024 Q3
PHARMAESSENTIA USA CORPORATION
RRlda.gov →
2024 Q2
NOVO NORDISK A/S
Q2lda.gov →
Showing recent filings · full history on lda.gov